Clarivate Plc (FRA:16A)

Germany flag Germany · Delayed Price · Currency is EUR
2.720
+0.020 (0.74%)
At close: Jan 6, 2026
-44.03%
Market Cap1.96B
Revenue (ttm)2.13B
Net Income (ttm)-337.51M
Shares Outn/a
EPS (ttm)-0.49
PE Ration/a
Forward PE5.24
Dividendn/a
Ex-Dividend Daten/a
Volume666
Average Volume33
Open3.000
Previous Close2.700
Day's Range2.720 - 3.000
52-Week Range2.400 - 5.300
Betan/a
RSI47.44
Earnings DateFeb 19, 2026

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, book... [Read more]

Industry Computer Programming, Data Processing, And Other Computer Related Services
Founded 1864
Employees 12,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 16A
Full Company Profile

Financial Performance

In 2024, Clarivate's revenue was $2.56 billion, a decrease of -2.74% compared to the previous year's $2.63 billion. Losses were -$668.00 million, -32.29% less than in 2023.

Financial numbers in USD Financial Statements

News

Goldman Sachs Downgrades Clarivate (CLVT) with Lower Price Target | CLVT Stock News

Goldman Sachs Downgrades Clarivate (CLVT) with Lower Price Target | CLVT Stock News

2 days ago - GuruFocus

Wall Street Breakfast Podcast: DHS Calls Out Hilton Over ICE

Hilton faces DHS ire after ICE agents were denied rooms at Minneapolis hotel. Hawaiian Electric reaches $47.75M shareholder settlement over wildfires. Clarivate unveils 2026 Drugs to Watch.

5 days ago - Seeking Alpha

Clarivate (CLVT) Highlights Key Therapies in 2026 Drugs to Watch Report

Clarivate (CLVT) Highlights Key Therapies in 2026 Drugs to Watch Report

5 days ago - GuruFocus

Clarivate Plc: Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient careLONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a ...

5 days ago - Finanz Nachrichten

Clarivate unveils 2026 Drugs to Watch highlighting 11 promising therapies

Clarivate’s 2026 Drugs to Watch report spotlights 11 high-potential therapies across cancer, metabolic, immune & rare diseases—see what trends to watch now.

5 days ago - Seeking Alpha

Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient care LONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a lea...

5 days ago - PRNewsWire

Clarivate Plc: Nissan Selects IPfolio from Clarivate

Managing IP with advanced workflow automation technology and leading dataLONDON, Dec. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence,...

24 days ago - Finanz Nachrichten

Nissan Selects IPfolio from Clarivate

Managing IP with advanced workflow automation technology and leading data LONDON , Dec. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, a...

24 days ago - PRNewsWire

CLVT Downgraded by Morgan Stanley with a Lowered Price Target | CLVT Stock News

CLVT Downgraded by Morgan Stanley with a Lowered Price Target | CLVT Stock News

25 days ago - GuruFocus

Clarivate (CLVT) Unveils AI-Powered Regulatory Intelligence Tool

Clarivate (CLVT) Unveils AI-Powered Regulatory Intelligence Tool

5 weeks ago - GuruFocus

Clarivate Plc: Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance

Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product lifecycleLONDON, Dec. 4, 2025 /PRNewswire/ -- Clarivate Pl...

5 weeks ago - Finanz Nachrichten

Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance

Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product lifecycle LONDON , Dec. 4, 2025 /PRNewswire/ -- Clarivate Plc ...

5 weeks ago - PRNewsWire

Insider Sell: Bar Veinstein Sells 309,902 Shares of Clarivate PLC (CLVT)

Insider Sell: Bar Veinstein Sells 309,902 Shares of Clarivate PLC (CLVT)

5 weeks ago - GuruFocus

Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI

New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom to operate, patentability, and infringement related decisions LONDON , Nov. 24, 2025 /PRNewswire/ -- Clarivate Plc...

6 weeks ago - PRNewsWire

Clarivate Plc (CLVT) Presents at Global Technology, Internet, Media & Telecommunications Conference 2025 Transcript

Clarivate Plc (CLVT) Global Technology, Internet, Media & Telecommunications Conference 2025 November 19, 2025 1:20 PM ESTCompany ParticipantsMatti Shem...

7 weeks ago - Seeking Alpha

Clarivate to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on November 19

LONDON , Nov. 13, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Matt Shem Tov, Chief Executive Officer, and Jonathan C...

2 months ago - PRNewsWire

Clarivate Announces Highly Cited Researchers 2025 List

Celebrating exceptional, community-wide excellence, based on rigorous evaluation and selection LONDON , Nov. 12, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transforma...

2 months ago - PRNewsWire

Is Clarivate Stock a Buy After a Member of the Board of Directors Bought Shares for $2.5 Million?

Key PointsKenneth L. Cornick, a member of the Board of Directors for Clarivate, purchased 725,000 shares in the company.

2 months ago - Nasdaq

Is Clarivate Stock a Buy After a Member of the Board of Directors Bought Shares for $2.5 Million?

Kenneth L. Cornick, a member of the Board of Directors for Clarivate, purchased 725,000 shares in the company. The purchase came a few days after Clarivate reported third quarter results on Oct. 29.

2 months ago - The Motley Fool

Fujifilm Selects IPfolio from Clarivate

Maximizing the value of intellectual property assets to support business growth LONDON , Nov. 6, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligen...

2 months ago - PRNewsWire

Clarivate: Downgrade To Hold As The Recovery Momentum Is Not Showing Up

Clarivate faces weak organic growth and flat revenue with challenges in key segments and slow recovery. Learn why CLVT stock is downgraded to hold.

2 months ago - Seeking Alpha

Clarivate PLC (CLVT) Q3 2025 Earnings Call Highlights: Strategic Innovations and Financial ...

Clarivate PLC (CLVT) Q3 2025 Earnings Call Highlights: Strategic Innovations and Financial Resilience Amidst Challenges

2 months ago - GuruFocus

Q3 2025 Clarivate PLC Earnings Call Transcript

Q3 2025 Clarivate PLC Earnings Call Transcript

2 months ago - GuruFocus

Clarivate Pulse of the Library Report Reveals Link Between AI Literacy, AI Implementation and Confidence

D rawing on insights from over 2,000 librarians representing academic, national and public libraries globally, the report offers an up-to-date view of how they are adapting to rapid change LONDON , Oc...

2 months ago - PRNewsWire

Decoding Clarivate PLC (CLVT): A Strategic SWOT Insight

Decoding Clarivate PLC (CLVT): A Strategic SWOT Insight

2 months ago - GuruFocus